AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN NON-HODGKINS-LYMPHOMAS - PREDICTION OF MONONUCLEAR CELL YIELD IN BONE-MARROW HARVESTS

被引:0
作者
RINALDI, C
SAVIGNANO, C
SILVESTRI, F
GEROMIN, A
CERNO, M
FANIN, R
BIFFONI, F
BACCARANI, M
机构
[1] UNIV UDINE HOSP,DEPT BONE MARROW TRANSPLANT,DIV HEMATOL,I-33100 UDINE,ITALY
[2] GEN HOSP,UDINE,ITALY
关键词
MONONUCLEAR CELL YIELD; BONE MARROW HARVEST; NHL; ABMT;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We retrospectively analyzed the actors influencing the mononuclear cell (MNC) yield of bone marrow (BM) harvests in a cohort of 15 non-Hodgkin's lymphoma patients undergoing autologous bone marrow transplantation. All the patients were treated with the F-MACHOP regimen and four of them also received radiotherapy on bulky disease. Before harvesting, the patients underwent complete peripheral blood (PB) count, BM biopsy and aspirate. WBC and MNC/mu L were determined on the pre-harvest PB and BM aspirate samples using an automated counter. The following variables were examined in univariate and multivariate regression analysis for possible influence on the MNC yield in the harvests: age, sex, number of cycles of CT, previous radiotherapy, state of the disease at the time of harvest, interval between the end of therapy and BM harvest, cellularity of the BM biopsy, absolute WBC and MNC counts in the PB before harvesting, absolute WBC and MNC counts in the BM aspirate performed before harvesting. The amount of marrow harvested was constant for all patients: 21.2 +/- 0.24 mL/kg B.W. Among the factors analyzed, two correlated strongly with the MNC yield/kg E.W. in the harvests: the MNC count in pre-harvest PB (r = 0.823; p = 0.0001) and the MNC count in pre-harvest BM aspirate (r = 0.802; p = 0.0003). A regression equation was generated that allows calculation of the MNC/kg yield prior to harvesting.
引用
收藏
页码:443 / 447
页数:5
相关论文
共 50 条
  • [1] AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA
    MCMILLAN, AK
    GOLDSTONE, AH
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1991, 46 (03) : 129 - 135
  • [2] DETECTION AND SIGNIFICANCE OF BONE-MARROW INFILTRATION AT THE TIME OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HODGKINS-DISEASE
    CHOPRA, R
    WOTHERSPOON, AC
    BLAIR, S
    MCMILLAN, AK
    MILLS, W
    FIELDING, AK
    LINCH, DC
    GOLDSTONE, AH
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (03) : 647 - 649
  • [3] LOW-DOSES OF RIL2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION INDUCE A PROLONGED IMMUNOSTIMULATION OF NK COMPARTMENT IN HIGH-GRADE NON-HODGKINS-LYMPHOMAS
    RASPADORI, D
    LAURIA, F
    VENTURA, MA
    TAZZARI, PL
    FERRINI, S
    MIGGIANO, MC
    RONDELLI, D
    TURA, S
    ANNALS OF HEMATOLOGY, 1995, 71 (04) : 175 - 179
  • [4] CLINICAL USE OF GM-CSF IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    CARELLA, AM
    GAOZZA, E
    PIATTI, G
    GIORDANO, D
    SANTINI, G
    CARLIER, P
    RAFFO, MR
    NATI, AS
    CONGIN, A
    BACIGALUPO, A
    DAMASIO, E
    SANTI, L
    MARMONT, AM
    INTERNATIONAL JOURNAL OF CELL CLONING, 1990, 8 : 279 - 282
  • [5] AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HODGKINS-DISEASE - A 5-YEAR SINGLE-CENTER EXPERIENCE
    AGER, S
    WIMPERIS, JZ
    TOLLIDAY, B
    JESTICE, K
    BASS, G
    BAGLIN, T
    MARCUS, RE
    LEUKEMIA & LYMPHOMA, 1994, 13 (3-4) : 263 - 272
  • [6] HIGH-DOSE MITOXANTRONE AND ETOPOSIDE CONDITIONING IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR RELAPSED HODGKINS-DISEASE
    LIM, SH
    BAGLIN, TP
    FLAVELL, DJ
    FLAVELL, SU
    WIMPERIS, JZ
    MARCUS, RE
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1992, 48 (02) : 110 - 114
  • [7] NATURAL-KILLER-CELL REGENERATION AFTER TRANSPLANTATION WITH MAFOSFAMIDE PURGED AUTOLOGOUS BONE-MARROW
    ALMICI, C
    MANONI, L
    CARLOSTELLA, C
    GARAU, D
    COTTAFAVI, L
    RIZZOLI, V
    BONE MARROW TRANSPLANTATION, 1995, 16 (01) : 95 - 101
  • [8] AUTOLOGOUS BONE-MARROW TRANSPLANTATION WITH 4-HYDROPEROXYCYCLOPHOSPHAMIDE-PURGED MARROW FOR ACUTE LYMPHOBLASTIC-LEUKEMIA
    GONZALESCHAMBERS, R
    PRZEPIORKA, D
    SHADDUCK, RK
    BOROCHOVITZ, D
    BLOOM, EJ
    COLVIN, OM
    MANGAN, KF
    ROSENFELD, CS
    MEDICAL AND PEDIATRIC ONCOLOGY, 1991, 19 (03): : 160 - 164
  • [9] MYELOABLATIVE THERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS CONSOLIDATION OF REMISSION IN PATIENTS WITH FOLLICULAR LYMPHOMA
    ROHATINER, AZS
    PRICE, CGA
    ARNOTT, S
    NORTON, A
    EVANS, ML
    COTTER, F
    DOREY, E
    DAVIS, CL
    CLARK, P
    STERLINI, J
    LIM, J
    HORTON, M
    LISTER, TA
    ANNALS OF ONCOLOGY, 1991, 2 : 147 - 150
  • [10] Red blood units collected from bone marrow harvests after mononuclear cell selection qualify for autologous use
    Leitner, G. C.
    Dettke, M.
    List, J.
    Worel, N.
    Weigel, G.
    Fischer, M. B.
    VOX SANGUINIS, 2010, 98 (03) : e284 - e289